Joint Working - Varied Success!
Amanda J Schofield
Quality Improvement Lead
Greater Manchester, Lancashire
& South Cumbria...
NHS | Presentation to [XXXX Company] | [Type Date]2
Overview
• A brief overview of each project
• What went well
• Barrier...
GMCCSN Joint Working Proposals
1.Mapping the provision of Anticoagulation Services
for patients with Atrial Fibrillation (...
1. GMCCSN, GMMMG & Boehringer Ingelheim
Initiation
• Government directive on Atrial Fibrillation and
stroke prevention
• N...
GMCCSN, GMMMG & Boehringer Ingelheim
Key Points
• Detailed joint working agreement
• Shared vision
• Shared project manage...
GMCCSN, GMMMG & Boehringer Ingelheim
Project Aims
• Examine care pathways for patients with AF
• Understand the provision ...
GMCCSN, GMMMG & Boehringer Ingelheim
Deliverables
• GM algorithms
• Care pathway
• GRASP AF implementation
• Most effectiv...
2. GMCCSN & Bayer Healthcare
Initiation
• GMMMG and GM commissioners agreement for GMCCSN
to look at the clinical pathway ...
GMCCSN & Bayer Healthcare
Key Points
• Detailed Joint working agreement drafted
• Shared vision
• Shared project managemen...
GMCCSN & Bayer Healthcare
Project Aims
• To improve and standardise the management of patients
with a DVT across Greater M...
GMCCSN & Bayer Healthcare
Outcome
• Not a joint working project
• Unanimous decision from project steering group members
•...
3.GMCCSN & Company A and Company B
Initiation
• Call to Balloon Time – national guidance 150 minutes
• A GM pathway flow p...
GMCCSN & Company A and Company B
Key Points
• Joint working agreements drafted
• Clinical engagement and agreement from th...
GMCCSN & Company A and Company B
Project Aims
• Ensure that all patients receive effective yet extremely
prompt assessment...
GMCCSN & Company A and Company B
Outcome
• Not a joint working project
• GM treatment pathway - competition
• Company B su...
Varied Success
• Patient focused
• Governance
• Shared benefits
• Pooled resources
• Engagement
• NHS Reconfiguration
• Co...
What does success look like?
• Have a clear understanding from beginning
• All cards on the table
• Detailed plans
• Commu...
Key Differences
NHS England GM Lancs & South Cumbria SCN & Senate 26/06/1318
Key differentiators
POOLING of resources by N...
Contact information:
Name: Amanda Schofield
Job title: Quality Improvement Lead
Company: Greater Manchester, Lancashire an...
Upcoming SlideShare
Loading in …5
×

Joint working varied success!

1,066 views

Published on

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,066
On SlideShare
0
From Embeds
0
Number of Embeds
776
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Connect patients to effective treatment and improve livesBy the management and direction of AF patients (GRASP)
  • Joint working varied success!

    1. 1. Joint Working - Varied Success! Amanda J Schofield Quality Improvement Lead Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate 26.06.13
    2. 2. NHS | Presentation to [XXXX Company] | [Type Date]2 Overview • A brief overview of each project • What went well • Barriers • Key points for future project
    3. 3. GMCCSN Joint Working Proposals 1.Mapping the provision of Anticoagulation Services for patients with Atrial Fibrillation (AF) across Greater Manchester (GM) – Boehringer Ingelheim (July 2010 – 2011) 2.The Management of Patients with Deep Vein Thrombosis in GM – Bayer Healthcare (February 2013 - Present) 3.Door In Door Out Project – Company A & Company B (January 2013 – Present) 3 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    4. 4. 1. GMCCSN, GMMMG & Boehringer Ingelheim Initiation • Government directive on Atrial Fibrillation and stroke prevention • New Oral Anticoagulants – Licensed • Commissioned by GM Association of PCT’s • Three way partnership • Open and Transparent 4 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    5. 5. GMCCSN, GMMMG & Boehringer Ingelheim Key Points • Detailed joint working agreement • Shared vision • Shared project management • Knowledge sharing • Pooling of resources • Outcomes were patient focused 5 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    6. 6. GMCCSN, GMMMG & Boehringer Ingelheim Project Aims • Examine care pathways for patients with AF • Understand the provision of anticoagulation services • Achieve the best outcomes for patients in terms of clinical efficacy and cost effectiveness • A controlled introduction from a financial and new clinical intervention perspective 6 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    7. 7. GMCCSN, GMMMG & Boehringer Ingelheim Deliverables • GM algorithms • Care pathway • GRASP AF implementation • Most effective prescribing for AF patients 7 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    8. 8. 2. GMCCSN & Bayer Healthcare Initiation • GMMMG and GM commissioners agreement for GMCCSN to look at the clinical pathway for Venous Thromboembolim (specifically DVT) • Extensive clinical support to evaluate the protocol and guidance • New oral anticoagulation therapy licensed for DVT • New NICE guidance released in June 2012 8 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    9. 9. GMCCSN & Bayer Healthcare Key Points • Detailed Joint working agreement drafted • Shared vision • Shared project management • Pooling of resources • Knowledge sharing • Outcome patient focused 9 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    10. 10. GMCCSN & Bayer Healthcare Project Aims • To improve and standardise the management of patients with a DVT across Greater Manchester • The development of a new protocol and pathway to manage patients with suspected DVT within Greater Manchester • The development of a structured, consistent and organised approach in the management of DVT • Improve patient outcomes 10 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    11. 11. GMCCSN & Bayer Healthcare Outcome • Not a joint working project • Unanimous decision from project steering group members • Historical suspicion • Bayer Healthcare invite • Standardised protocol development continues • Collaborative GMMMG prescribing guidance 11 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    12. 12. 3.GMCCSN & Company A and Company B Initiation • Call to Balloon Time – national guidance 150 minutes • A GM pathway flow problem had been indentified • Project mandated by GMCCSN Cardiac Board • Door – In – Door – Out (DIDO) steering group • GMCCSN approached by company A to work jointly • Advice from GMMMG to approach Company B NHS | Presentation to [XXXX Company] | [Type Date]12
    13. 13. GMCCSN & Company A and Company B Key Points • Joint working agreements drafted • Clinical engagement and agreement from the beginning • Agreement patient outcome focused • Individual companies input • Pooling of resources • NHS reconfiguration NHS | Presentation to [XXXX Company] | [Type Date]13
    14. 14. GMCCSN & Company A and Company B Project Aims • Ensure that all patients receive effective yet extremely prompt assessment and referral from their local ED to the heart attack centre for their treatment. • Target DIDO time of 30 minutes across GM. 14 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    15. 15. GMCCSN & Company A and Company B Outcome • Not a joint working project • GM treatment pathway - competition • Company B supporting training and sponsorship • Openness and transparency • NHS reconfiguration • Communication • Time 15 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    16. 16. Varied Success • Patient focused • Governance • Shared benefits • Pooled resources • Engagement • NHS Reconfiguration • Communication • A Competitive market 16 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    17. 17. What does success look like? • Have a clear understanding from beginning • All cards on the table • Detailed plans • Communication (internal/external) • Leadership • Decision makers – who are they? • Trust • Commitment 17 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13
    18. 18. Key Differences NHS England GM Lancs & South Cumbria SCN & Senate 26/06/1318 Key differentiators POOLING of resources by NHS/pharmaceutical company(ies) Detailed joint working agreement Outcomes (for patients, NHS, company(ies)) clearly articulated and measured Details of arrangements made public
    19. 19. Contact information: Name: Amanda Schofield Job title: Quality Improvement Lead Company: Greater Manchester, Lancashire and South Cumbria SCN and Senate Email: a.schofield1@nhs.net Tel: 07795127368 19 NHS England GM Lancs & South Cumbria SCN & Senate 26/06/13

    ×